64Cu-TLX592

· Telix Pharmaceuticals (Innovations) Pty Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 64Cu-TLX592, covering 2024-05-01 to 2024-05-01. Get the full timeline:

Most recent: Clinical Trial Update: 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study) [EARLY_Phase 1]